Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
san diego blog main
akcea therapeutics
anylam pharmaceuticals
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
cardiomyopathy
drugs
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
inotersen
joshua brumm
kaleido biosciences
muscular dystrophy
myotonic dystrophy type 1
neuropathy
new york
new york top stories
news
onpattro
patisiran
pfizer
rare disease drugs
romesh subramanian
san diego top stories
san francisco blog main
susanna high
What
ago
4
×
drug
4
×
medicines
4
×
available
genetic
rare
add
akcea
alnylam
amyloidosis
approved
attr
bacteria
battle
better
biotechs
block
companies
company
considering
contaminated
contributed
crisis
data
days
debilitating
deeply
described
different
disease
diseases
drugs
dyne
early
expanded
expected
experimental
explained
eyes
fda
Language
unset
Current search:
medicines
×
drug
×
ago
×
@bgr.com
1 year ago
New drug recall: 67 medicines might be contaminated – here’s the full list
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techdirt.com
4 years ago
Another Way In Which Patents Contributed To The Opioid Crisis: Hospitals Ordered Not To Use Better, Less Problematic Medicines
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea